After Moderna, Oxford’s COVID-19 Vaccine Yields Positive Immunity Results

 

The Team from Oxford University has revealed people in their studies are showing signs of immunity, as they have been working on separate experimental jabs for months to try to protect millions of people from catching the coronavirus in future. This is certainly a ray of hope, following yesterday’s positive news from Moderna in the US.

Oxford scientists have already said they are ’80 per cent’ confident they can have their jab available by September.

People being given the Oxford vaccine have been developing antibodies and white blood cells called T-cells which will help their bodies fight off the virus if they get infected, it is reported.

 

 

One source on the Oxford project told ITV News: ‘An important point to keep in mind is that there are two dimensions to the immune response: antibodies and T-cells.

‘Everybody is focused on antibodies but there is a growing body of evidence suggesting that the T-cells response is important in the defence against coronavirus.’

Oxford’s phase 3 trial is involving around 8,000 people across the UK and also up to 6,000 people in Brazil and South Africa, where the jab may be easier to test because more people are infected with the coronavirus.

The vaccine is being manufactured by AstraZeneca, based in Cambridge, England, and millions of doses have already been ordered by Number 10 in the hope that it will work.

Bay Way Hoodie (Unisex)

Our limited-edition hoodie just dropped. Grab yours now!